Impact of a primary care physician workshop on osteoporosis medical practices

Osteoporosis International

Volumn 21, Issue 9, 2010, Pages 1471-1485

  Laliberte M C ^a,b   Perreault, S ^a   Dragomir, A ^a   Goudreau, J ^a,b   Rodrigues, I ^a,c   Blais, L ^a   Damestoy, N ^d   Corbeil, D ^c   Lalonde, L ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Hopital de la Cite de la Sante   (Canada)

^c CLSC   (Canada)

^d Centre de Sante et de Services Sociaux de Laval   (Canada)

Author keywords

Cohort study; Osteoporosis; Preventive practices; Primary care; Primary care physician; Workshop

Indexed keywords

CALCIUM; GLUCOCORTICOID; VITAMIN D;

ARTICLE; BONE DENSITY; FOLLOW UP; FRACTURE; HUMAN; LONG TERM CARE; MEDICAL PRACTICE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CLINICAL COMPETENCE; EDUCATION, MEDICAL, CONTINUING; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE; PROFESSIONAL PRACTICE; QUEBEC;

EID: 77956457681     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1116-6     Document Type: Article

References (45)

1. European Foundation for Osteoporosis and the National Osteoporosis Foundation (1997) Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 7 (1):1-6
2. Osteoporosis Canada. About osteoporosis: What is osteoporosis? Available from: http://www.osteoporosis.ca/english/About%20Osteoporosis/what-is/default. asp?s=1. Accessed 11 Aug. 2008
3. National Osteoporosis Foundation. Fast facts on osteoporosis. Available from: http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed 11 Aug. 2008
4. Papaioannou A, Giangregorio L, Kvern B et al (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11
5. Perreault S, Dragomir A, Desgagne A et al (2005) Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 14 (10):685-695
6. Giangregorio L, Papaioannou A, Cranney A et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35 (5):293-305
7. Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15 (10):767-778
8. Goudreau J, Rodrigues I, Lalonde L et al (2005) Faire connaître les recommandations d'un guide de pratiques: développement et évaluation d'une intervention de formation continue. Pédagogie Médicale 6 (3):147-159
9. Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 (10 Suppl): S1-S34
10. American Geriatrics Society-British Geriatrics Society-American Academy of Orthopaedic Surgeons Panel on Falls Prevention (2001) Guideline for the prevention of falls in older persons. J Am Geriatr Soc 49 (5):664-672
11. Régie de l'assurance maladie du Québec. Rapport annuel de gestion 2005-2006. Available from: http://www.ramq.gouv. qc.ca/fr/publications/ documents/rapp0506/rapp-annuel-0506-completpdf. Accessed 26 May 2007
12. Tamblyn R, Lavoie G, Petrella L et al (1995) The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 48 (8):999-1009
13. Blouin J, Dragomir A, Ste-Marie LG et al (2007) Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. J Clin Endocrinol Metab 92 (3):887-894
14. Perreault S, Dragomir A, Blais L et al (2008) Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf 17 (3):248-259
15. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 (3):321-333
16. Brown JP, Fortier M, Frame H et al (2006) Canadian consensus conference on osteoporosis, 2006 update. J Obstet Gynaecol Can 28(2 Suppl 1):S95-S112
17. Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257 (4):374-384
18. Gums J, Tovar J (2005) Adrenal gland disorders. In: DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey M (eds) Pharmacotherapy: a pathophysiologic approach, 6th edn. McGraw-Hill, New York, p 1403
19. Pack AM, Morrell MJ (2004) Epilepsy and bone health in adults. Epilepsy Behav 5(Suppl 2):S24-S29
20. Wawrzynska L, Tomkowski WZ, Przedlacki J et al (2003) Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism. Pathophysiol Haemost Thromb 33 (2):64-67
21. Tamler R, Epstein S (2006) Nonsteroid immune modulators and bone disease. Ann N Y Acad Sci 1068:284-296
22. Qaseem A, Snow V, Shekelle P et al (2008) Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148 (9):680-684 (Pubitemid 351669113)
23. Reid RL, Blake J, Abramson B et al (2009) SOGC clinical practice guidelines: Menopause and osteoporosis update 2009. J Obstet Gynaecol Can 31 (1): Supplement 1
24. Curtis JR, Westfall AO, Allison J et al (2007) Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 167 (6):591-596
25. Solomon DH, Katz JN, La Tourette AM et al (2004) Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 51 (3):383-387
26. Hansen KE, Rosenblatt ER, Gjerde CL et al (2007) Can an online osteoporosis lecture increase physician knowledge and improve patient care? J Clin Densitom 10 (1):10-20
27. Ioannidis G, Thabane L, Gafni A et al (2008) Optimizing care in osteoporosis: the Canadian quality circle project. BMC Musculoskelet Disord 9:130
28. Solomon DH, Polinski JM, Stedman M et al (2007) Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 22 (3):362-367
29. Solomon DH, Katz JN, Finkelstein JS et al (2007) Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 22 (11):1808-1815
30. Majumdar SR, Beaupre LA, Harley CH et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167 (19):2110-2115
31. Davis JC, Guy P, Ashe MC et al (2007) HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 62 (8):888-891
32. Feldstein A, Elmer PJ, Smith DH et al (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54 (3):450-457
33. Cranney A, Lam M, Ruhland L et al (2008) A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int 19 (12):1733-1740
34. Majumdar SR, Johnson JA, McAlister FA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178 (5):569-575
35. Ashe M, Khan K, Guy P et al (2004) Wristwatch-distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. J Hand Ther 17 (3):324-328
36. Lafata JE, Kolk D, Peterson EL et al (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22 (3):346-351
37. Levy BT, Hartz A, Woodworth G et al (2009) Interventions to improving osteoporosis screening: an Iowa Research Network (IRENE) study. J Am Board Fam Med 22 (4):360-367
38. Bero LA, Grilli R, Grimshaw JM et al (1998) Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ 317 (7156):465-468
39. Davis DA, Thomson MA, Oxman AD et al (1995) Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 274 (9):700-705
40. Davis D, O'Brien MA, Freemantle N et al (1999) Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 282 (9):867-874
41. Davis DA, Taylor-Vaisey A (1997) Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157 (4):408-416
42. Jaglal SB, Carroll J, Hawker G et al (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician 49:462-468
43. Yuksel N, Majumdar SR, Biggs C et al (2009) Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int [Epub 2009 Jun. 5]
44. McDonough RP, Doucette WR, Kumbera P et al (2005) An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health 8 (1):24-31
45. Von Korff M, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45 (2):197-203